Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | 2 placebo tablets matching acetaminophen 250 mg and aspirin 250 mg tablets Placebo: 2 placebo tablets matching acetaminophen 250 mg and aspirin 250 mg tablets | None | None | 0 | 415 | 0 | 415 | View |
| Acetaminophen 250 mg and Aspirin 250 mg | 2 tablets each containing Acetaminophen 250 mg and aspirin 250 mg Acetaminophen 250 mg and Aspirin 250 mg: 2 tablets each containing Acetaminophen 250 mg and Aspirin 250 mg | None | None | 1 | 408 | 0 | 408 | View |
Serious Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| intraductal profilerative breast lesion | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |